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following diagnosis: 2 of larynx, 3 oropharynx, 2 oral cavity, 2 unknown cervical metastasis, 2 nasopharynx, 1 hypopharynx, 1
paranasal sinus.
Results. The most of replanning was performed by weight loss secondary to mucositis, despite closed attention by the nursing
and nutritionist staff. In the graphical results are expressed lost weight and changes in the volume of primary PTV. Is made a
Pearson’s regression study and it is observed, despite the small number of patients, the decreased amount of the PTVs between
0 and 60 cm3, is independent of the amount of weight loss of the patient.
Conclusions. (a) IMRT maximizes tumor coverage and sparing of critical organs (OARs). Anatomical changes are more dramatic
than in conventional treatments because of the sharp dose gradients between edges of the target volume and OARs. (b) In this
work is observed that the decreased amount of the PTVs between 0 and 60 cm3, is independent of the amount of weight loss of
the patient. Replanning is required from anatomical changes produced of losing weight and is independent of the amount. (c) Is
necessary in treatment planning, the continuing education of staff members who attend.
http://dx.doi.org/10.1016/j.rpor.2013.03.270
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Background. Rarely oral cavity carcinoma is diagnosed in asymptomatic phase of growth grade squamous cell tumors. The purpose
of this study was to determine the relationship between symptoms/signs of the disease leading to the delay between the start
of the same and diagnosis (TDD), as well as between diagnosis and initiation of treatment (TDT).
Methods. We review a database of 381 patients of primary squamous cell carcinoma of head and neck between 1992 and 2011.
We selected 92 patients with tumor localization in oral cavity. We included demographic, clinical and tumor characteristics.
Univariate analysis was performed to examine the association of the main symptoms of the disease with TDD and TDT. A p
value less than or equal to 0.05 was considered statistically signiﬁcant. The analysis was performed using SPSS 12.0.
Results. The median age was 63 years (interquartile range=17). Most belonged to males (92.4%). The main symptoms distribution
was in the following order: pain (30.7%), mass (22.7%), ulceration (20.5%), lymphadenopathy (10.2%), dysphonia (5.7%), dysphagia
(3.4%), neurological symptoms (2.3%), itching (2.3%), foreign body sensation (1.1%) and bleeding (1.1%). The median follow-up
of the cohort was 19.3 months (interquartile range=26.3) TDD median was 69 days (interquartile range=108 days). The only
sign that he was associated, was ulceration: positive, with 196 days, vs. negative, with 108 (F=5.012, p= .028). Moreover, the
median for the TDT was 18 days (interquartile range=25 days) and was associated with signs/symptoms of lymphadenopathy
and mass. There were also signiﬁcant differences in the treatments of surgery alone (if = 7 days vs. not = 23, F=6.675, p= .011) and
radiotherapy alone (if: 48 days vs. not = 20, F=4.123, p= .045).
Conclusions. The TDD was associated with signs/symptoms of ulceration and this may be due to patient factors or health system
factors. The TDT was associated with signs/symptoms of lymphadenopathy and mass, probably by the choice of treatment in
these cases, as also demonstrated its by association with surgery and radiation treatments exclusive.
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Introduction. IMRT, IGRT and 18FDG PET-CT planning is a multimodal combination that allows improving the accuracy of the
planning and treatment delivery in patients with LALC.
Objectives. To assess clinical and acute toxicity outcomes of LALC patients irradiated at our institution, using 18 FDG PET-CT, IMRT
and IGRT. Methods: Between December 2007 and November 2012, all LALC patients treated with radiotherapy at our institution
were included in this analysis.
Results. A total of 43 LALC patients were analyzed. While the 53.5% of patients (23/43) were irradiated with adjuvant intent, the
remaining 20 patients (46.5%) received radical radiotherapy. According to radiation treatment, IMRT was used in the 83.7%
(37/43) of the patients and 3DRT in 16.3%. CT was used for treatment planning in 19 patients (44.2%) and 18FDG PET-CT
in 24 patients (55.8%). Prescription dose in 81.4% of patients (N: 35) was 66Gy in 30 fractions of 2.2Gy per fraction (Inte-
grated Boost) in the areas of gross disease and 54Gy in 30 fractions of 1.8Gy in areas of microscopic involvement risk.
Treatment veriﬁcation in all cases was Cone Beam-CT (IGRT). A total of 13 patients out of 43 (30.2%) were carriers of gas-
trostomy feeding tube. The mean follow-up was 12 months (median 8 months; range 0.5–58.6 months) with a 1-year local
failure free survival (LFFS) of 94% and an actuarial 2-year LFFS of 90.2%. Acute toxicity G3-G4 was reported in 17.6% of
patients.
